Search clinical trials for: IV meropenem

Total 3353 results

Qilu Pharmaceutical Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)

Healthy

China
Mahidol University

Unknown

Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections

Drug Safety

Thailand
Sutep Jaruratanasirikul
Prince of Songkla University

Completed

The Pharmacodynamics of Meropenem in Patient With Ventilator-associated Pneumonia

Ventilator-Associated Pneumonia

Thailand
TASK Applied Science

Completed

Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Mical Paul
European Commission

Completed

Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem

Gram-Negative Bacterial Infections

Israel, Greece, Italy
GlaxoSmithKline

Terminated

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

Infections, Intestinal

United States, Czechia, Russian Federation, Spain, Canada, France, Italy
Kompetenznetz Sepsis
Bayer; AstraZeneca

Completed

Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock (MaxSep)

Septic Shock | Severe Sepsis

Germany
Mahidol University

Completed

Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients

Sepsis | Critical Illness | Septic Shock | Morality | Pharmacokinetic | Carbapenem | Pharmacodynamic | Clinical Outcome | Organ Failure, Multiple

Thailand
Austin Health

Completed

A Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Unit (ICU) Patients (MERO001)

Sepsis

Australia
Unity Health Toronto
Sunnybrook Health Sciences Centre; University of Toronto

Terminated

Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients

Cystic Fibrosis Pulmonary Exacerbation

Canada
Oslo University Hospital

Recruiting

A Pilot Study for Optimizing Meropenem Administration in the ICU (MER6)

Drug Effect

Norway
Xinhua Hospital, Shanghai Jiao Tong University...

Completed

Efficacy and Pharmacokinetics of Meropenem in Severe Septic Patients

Sepsis

China
University of Florida

Terminated

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Bacterial Pneumonia

United States, Spain, France, Germany
Qingtao Zhou

Completed

Meropenem Dosage Strategy Based on PPK Model

Lower Respiratory Tract Infection

China
Mansoura University

Completed

Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset Sepsis (BVPIMNBLOS)

Late Onset Neonatal Sepsis
Seattle Children's Hospital
Cystic Fibrosis Foundation

Completed

Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)

Cystic Fibrosis | Chronic Bronchitis

United States
Joseph Kuti
Thrasher Research Fund

Completed

Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children

Pneumonia | Cystic Fibrosis | Pseudomonas Aeruginosa Infection

United States
Hannover Medical School

Unknown

Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis

Liver Cirrhosis | Peritonitis Bacterial

Germany
Pfizer

Completed

A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died

Pancreatitis, Acute Necrotizing

United States, Canada
The Emmes Company, LLC
The Emmes Company, LLC

Completed

Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections

Necrotizing Enterocolitis | Intra-abdominal Infection

United States
PENTA Foundation
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis (NeoMero-2)

Meningitis

United Kingdom
Prince of Songkla University

Recruiting

PK of Meropenem in Patients on Plasma Exchange

Autoimmune Diseases

Thailand
Assiut University

Not yet recruiting

Meropenem vs Cefotaxime as Empirical Treatment of SBP

Spontaneous Bacterial Peritonitis
Antabio

Completed

FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects

Healthy Volunteers

France
Hoffmann-La Roche

Completed

A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants

Gram-negative Bacterial Infections

United States
Hoffmann-La Roche

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers

Healthy Volunteers

United States
University of Padova

Terminated

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Cirrhosis | Ascites | Nosocomial Spontaneous Bacterial Peritonitis

Italy
TASK Applied Science
GlaxoSmithKline; Research Center Borstel; Eduardo Mondlane University; Barcelona...

Completed

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Rempex (a wholly owned subsidiary of Melinta Therapeutics...
Department of Health and Human Services

Completed

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Bacteremia | Acute Pyelonephritis | Ventilator-associated Bacterial Pneumonia | Urinary Tract Infection Complicated | Hospital Acquired Bacterial Pneumonia | Abdominal Infection

Italy, United States, Colombia, Greece, Israel, Brazil, Argentina, United Kingdom
Mohamed Gaber Allam
King Abdul Aziz Specialist Hospital

Completed

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

Patients With Respiratory Failure and Shocked

Saudi Arabia
Merck Sharp & Dohme LLC

Terminated

Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)

Urinary Tract Infections
Arrevus Inc.
Arnasi Group

Completed

Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients

Melioidosis

Thailand
University of Michigan

Completed

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

Pneumonia | Blood Stream Infection

United States, Israel, Thailand, Greece, Bulgaria, Italy, Taiwan
Assistance Publique - Hôpitaux de Paris
Groupe Hospitalier Paris Saint Joseph; French National Network of Clinical...

Completed

Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections (TEMO-CARB)

Urinary Tract Infections

France
Ziauddin University

Completed

Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children ([XDRTYPHOID])

Typhoid Fever

Pakistan
Venus Remedies Limited

Completed

CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria (PLEA)

Acute Pyelonephritis | Urinary Tract Infection Complicated

India
Xiangya Hospital of Central South University

Unknown

Second-generation Sequencing Guides the Treatment of Severe Pneumonia (NGS)

Pneumonia | Metagenomic Next Generation Sequencing

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection

Mental Health Issue

China
The University of Queensland

Completed

Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response (MERINO II)

Bloodstream Infections

Singapore, Australia
Fundación Pública Andaluza para la gestión de la...
Spanish Network for Research in Infectious Diseases

Completed

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli (FOREST)

Infection Due to ESBL Escherichia Coli

Spain
Jinling Hospital, China

Unknown

Glue Application in the Treatment of Low-Output Fistulas (FG-treatment)

Low-output External Gastrointestinal Fistula

China
Coordinación de Investigación en Salud, Mexico
Instituto Mexicano del Seguro Social; Hospital Infantil de Mexico Federico... and other collaborators

Completed

Efficacy of Betalactam Antibiotics in Prolonged Infusion Compared to Intermittent in Pediatric Patients With Sepsis

Sepsis

Mexico
Replidyne

Completed

A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media

Otitis Media

Costa Rica, Israel
Replidyne
INC Research Limited

Terminated

A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis

Chronic Bronchitis

United States
Benazir Bhutto Hospital, Rawalpindi

Completed

Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic Antibiotics

Acute Pancreatitis

Pakistan
Mabaret Al-Asafara Hospitals

Unknown

Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.

Drug Toxicity

Egypt
Medical University of Lublin
University of Warmia and Mazury in Olsztyn

Completed

Pharmacokinetics of Meropenem During High-dose CRRT

Renal Failure | Infection

Poland
Hoffmann-La Roche

Completed

A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection

Urinary Tract Infections

United States, Serbia, Hungary, Latvia, Poland
Pfizer

Completed

Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis

Pancreatitis

Colombia
National Institutes of Health Clinical Center (CC)

Completed

Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients

Bacterial Infections

United States

Search clinical trials for: IV meropenem

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations